Positron emission tomography of high-grade gliomas

Research output: Contribution to journalArticlepeer-review


High-grade gliomas [HGG (WHO grades III–IV)] are almost invariably fatal. Imaging of HGG is important for orientating diagnosis, prognosis and treatment planning and is crucial for development of novel, more effective therapies. Given the potentially unlimited number of usable tracing molecules and the elevated number of available radionuclides, PET allows gathering multiple informations on HGG including data on tissue metabolism and drug pharmacokinetics. PET studies on the diagnosis, prognosis and treatment of HGG carried out by most frequently used tracers and radionuclides (11C and 18F) and published in 2014 have been reviewed. These studies demonstrate that a thorough choice of tracers may confer elevated diagnostic and prognostic power to PET imaging of HGG. They also suggest that a combination of PET and MRI may give the most complete and reliable imaging information on HGG and that research on hybrid PET/MRI may be paying back in terms of improved diagnosis, prognosis and treatment planning of these deadly tumours.

Original languageEnglish
Pages (from-to)1-11
Number of pages11
JournalJournal of Neuro-Oncology
Publication statusAccepted/In press - Feb 20 2016


  • Astrocytoma
  • Glioblastoma
  • Magnetic resonance imaging
  • Radiotherapy planning

ASJC Scopus subject areas

  • Clinical Neurology
  • Cancer Research
  • Oncology
  • Neurology


Dive into the research topics of 'Positron emission tomography of high-grade gliomas'. Together they form a unique fingerprint.

Cite this